Regulations.gov document
Attachment 2 - Current Package insert for the reference-listed drug, Phenylephrine…
Supporting & Related Material · FDA-2025-P-6893 · posted Dec 10, 2025
Key facts
| Document ID | FDA-2025-P-6893-0004 |
|---|---|
| Title | Attachment 2 - Current Package insert for the reference-listed drug, Phenylephrine Hydrochloride in 0.9% Sodium Chloride injection, 20 mg in 250 mL (0.08 mg/mL)-NDA 216830 Revision 05/2025; Source: Drugs@FDA |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2025-P-6893 |
| Posted | Dec 10, 2025 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: